D’Souza replaces James Howard-Tripp as president and CEO.
Labopharm said the board of directors of the organization in conjunction with the management has undertaken a complete review of the business including consideration of all available strategic options.
Labopharm chairman Santo Costa said they are delighted to have Mark’s knowledge and experience to lead the Corporation forward.
"We are very grateful to Jim for his efforts on behalf of the Corporation over the last eleven (11) years," Costa said.